We use cookies to make your visit to our website as pleasant as possible. If you continue to use the website, you agree to our privacy policy and to the use of cookies. More information about cookies and how ImpediMed uses them is available here.
Accept Cookies
CLINICAL PRACTICE GUIDELINES
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship
Learn More
NCCN GUIDELINES®|Learn More
Ward, L., et al.

Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy.

The choice of the mean + 3 SD as the criterion value may be questioned as being too conservative compared to a criterion of the mean + 2 SD more common in diagnostic testing. This threshold value was originally proposed by Cornish et al. but without supporting explanation for its choice. Its use in the present study was based upon this historical precedent.

Ward, L., et al., Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphatic Research and Biology, 2011. 9(1): p. 47-51

Open access: No
View